PEPTC VACCINES LIMITED

Active London

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
P

PEPTC VACCINES LIMITED

Research and experimental development on biotechnology

Founded 21 Apr 2020 Active London, England 0 employees website.com
Research and experimental development on biotechnology

Previous Company Names

TC VACCINES LIMITED 23 Apr 2020 — 14 May 2020
TC BIOPHARMA LIMITED 21 Apr 2020 — 23 Apr 2020
Accounts Submitted 19 Dec 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 17 Dec 2025 Next due 21 Dec 2026 7 months remaining
Net assets £-273K £45K 2024 year on year
Total assets £4K £60K 2024 year on year
Total Liabilities £277K £15K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

1st Floor 40-44 Newman Street London W1T 1QD England

Full company profile for PEPTC VACCINES LIMITED (12567263), an active company based in London, England. Incorporated 21 Apr 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£4.22k

Net Assets

-£272.75k

Decreased by £45.21k (-20%)

Total Liabilities

£276.97k

Decreased by £15.15k (-5%)

Turnover

N/A

Employees

N/A

Decreased by 4 (-100%)

Debt Ratio

6565%

Increased by 6113 (+1352%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

6 Allotments 63,282 Shares £2.14m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
25 Nov 20205,000$5$0.001
19 Oct 2020750$0.75$0.001
30 Sept 20201,750$1.75$0.001
28 Sept 202016,300$16.3$0.001
15 Sept 20203,750$3.75$0.001

Officers

Officers

2 active 1 resigned
Status
Hallgarten, Daniel ArthurDirectorBritishUnited Kingdom6421 Apr 2020Active
Ian KaretDirectorBritishEngland6326 Jun 2020Active

Shareholders

Shareholders (1)

Treos Bio Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Peter Kadas

British

Active
Notified 7 Dec 2021
Residence England
DOB February 1962
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 Jan 2026OfficersChange to director Mr Daniel Arthur Hallgarten on 20 Jan 2026
20 Jan 2026Persons With Significant ControlChange to Mr Peter Kadas as a person with significant control on 20 Jan 2026
19 Dec 2025AccountsAnnual accounts made up to 31 Dec 2024
17 Dec 2025Confirmation StatementConfirmation statement made on 7 Dec 2025 with updates
11 Dec 2025OtherNotice of agreement to exemption from audit of accounts for period ending 31/12/24
20 Jan 2026 Officers

Change to director Mr Daniel Arthur Hallgarten on 20 Jan 2026

20 Jan 2026 Persons With Significant Control

Change to Mr Peter Kadas as a person with significant control on 20 Jan 2026

19 Dec 2025 Accounts

Annual accounts made up to 31 Dec 2024

17 Dec 2025 Confirmation Statement

Confirmation statement made on 7 Dec 2025 with updates

11 Dec 2025 Other

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

Recent Activity

Latest Activity

Change to director Mr Daniel Arthur Hallgarten on 20 Jan 2026

3 months ago on 20 Jan 2026

Change to Mr Peter Kadas as a person with significant control on 20 Jan 2026

3 months ago on 20 Jan 2026

Annual accounts made up to 31 Dec 2024

4 months ago on 19 Dec 2025

Confirmation statement made on 7 Dec 2025 with updates

4 months ago on 17 Dec 2025

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

5 months ago on 11 Dec 2025